Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
Total Revenue |
10,980 |
1,707 |
1,683 |
2,588 |
Cost of Revenue |
7,635 |
1,083 |
1,144 |
1,605 |
|
Gross Profit |
3,345 |
624 |
539 |
983 |
|
|
Operating Expenses |
|
Research Development |
82 |
116 |
82 |
(103) |
|
Selling General and Administrative |
2,348 |
989 |
1,093 |
1,322 |
|
Non Recurring |
– |
– |
– |
– |
|
Others |
– |
– |
– |
– |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
Operating Income or Loss |
915 |
(481) |
(636) |
(236) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
371 |
11 |
(221) |
(1,915) |
|
Earnings Before Interest And Taxes |
1,286 |
(470) |
(857) |
(2,151) |
|
Interest Expense |
106 |
37 |
– |
9 |
|
Income Before Tax |
1,180 |
(507) |
(857) |
(2,160) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
1,180 |
(507) |
(857) |
(2,160) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
Net Income |
1,180 |
(507) |
(857) |
(2,160) |
Preferred Stock And Other Adjustments |
(152) |
154 |
(240) |
(1,089) |
|
Net Income Applicable To Common Shares |
1,028 |
(353) |
(1,097) |
(3,249) |
|